Valuation: Evaxion A/S

Market Cap 2.54Cr 2.27Cr 2.1Cr 1.9Cr 3.55Cr 241.4Cr 3.6Cr 25Cr 10Cr 126.31Cr 9.51Cr 9.31Cr 400.05Cr P/E 2026 *
-76x
P/E 2027 * -203x
Enterprise Value 2.54Cr 2.27Cr 2.1Cr 1.9Cr 3.55Cr 241.4Cr 3.6Cr 25Cr 10Cr 126.31Cr 9.51Cr 9.31Cr 400.05Cr EV / Sales 2026 *
-
EV / Sales 2027 * 5.43x
Free-Float
58.26%
Yield 2026 *
-
Yield 2027 * -
1 day+2.30%
1 week-23.21%
Current month-5.18%
1 month-6.89%
3 months+7.61%
6 months-25.60%
Current year-34.80%
1 week 2.93
Extreme 2.93
4
1 month 2.72
Extreme 2.72
4.5
Current year 2.72
Extreme 2.72
5.48
1 year 2.72
Extreme 2.72
6.92
3 years 1.2
Extreme 1.2
68.05
5 years 1.2
Extreme 1.2
1,252
10 years 1.2
Extreme 1.2
1,252
Manager TitleAgeSince
Chief Executive Officer 59 24/11/2025
Corporate Officer/Principal 49 11/08/2008
Director of Finance/CFO 53 01/11/2024
Director TitleAgeSince
Chairman 58 25/11/2020
Director/Board Member 56 01/01/2018
Director/Board Member 68 25/05/2021
Date Insider Type Main position Quantity % Market Cap. Importance
16/04/26 Other

Director

2,376 0.0006%
18/03/26 Other

Chief Financial Officer

6,45,750 0.1549%
18/03/26 OtherCompany 3,60,406 0.0864%
Change 5-day change 1-year change 3-year change Capi.($)
+2.30%-23.21%-49.27%-92.22% 2.54Cr
+0.65%-3.56%+33.53%+60.50% 6.35TCr
+1.76%+2.10%+12.10%+81.21% 5.45TCr
-0.94%+0.77%+8.85%+100.19% 5.36TCr
+2.76%+4.18%+28.34%+55.07% 4.48TCr
+2.00%-2.90%+18.37%+119.04% 4.16TCr
+1.34%-3.98%+225.44%+914.08% 3.99TCr
+0.64%-3.85%+11.71%+45.57% 3.25TCr
+29.06%+48.65%+106.84%+92.73% 2.67TCr
+3.72%-7.45%+24.25%-2.99% 2.34TCr
Average +4.33%-2.87%+42.02%+137.32% 3.8TCr
Weighted average by Cap. +3.23%-0.29%+47.55%+161.45%

Financials

2026 *2027 *
Net sales - 46.7L 41.88L 38.66L 35.06L 65.33L 44Cr 66.23L 4.62Cr 1.84Cr 23Cr 1.75Cr 1.72Cr 74Cr
Net income -1.56Cr -1.4Cr -1.29Cr -1.17Cr -2.18Cr -148.16Cr -2.21Cr -15Cr -6.13Cr -78Cr -5.84Cr -5.72Cr -245.53Cr -1.18Cr -1.06Cr -97.78L -88.68L -1.65Cr -112.47Cr -1.68Cr -12Cr -4.66Cr -59Cr -4.43Cr -4.34Cr -186.39Cr
Net Debt - -
Projected Income Statement - Annual - Evaxion A/S
Logo Evaxion A/S
Evaxion A/S, formerly known as Evaxion Biotech A/S, is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.
Employees
46
Date Price Change Volume
28/26/28 $3.110 +2.30% 51,036
27/26/27 $3.040 -1.30% 75,745
26/26/26 $3.080 -18.09% 2,20,554
23/26/23 $3.760 +1.35% 1,61,905
22/26/22 $3.710 0.00% 1,07,928
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Evaxion A/S
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.040USD
Average target price
12.25USD
Spread / Average Target
+302.96%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Evaxion A/S
  1. Stock Market
  2. Stocks
  3. EVAX Stock